JUBLPHARMANSEJubilant Pharmova LimitedMinimalNeutral
Announced Sat, 23 May · 14:44 IST

Jubilant Pharmova Limited has informed the Exchange about Copy of Newspaper Publication

JUBLPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.8%1-day move
₹998.00
prior close
₹1006.45
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-3.9-4.4-4.4-4.7-0.8-0.8-0.5-2.2-2.6-3.1-2.1-3.4-2.4
Up moveDown movePending
AI summary

Jubilant Pharmova Limited has published its audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The Audit Committee reviewed the results on May 21, 2026, and the Board of Directors approved them at a meeting held on May 22, 2026. The results were published in Financial Express (English) and Hindustan & Jansatta (Hindi) newspapers on May 23, 2026. The detailed results along with auditor reports have been posted on the company's website and stock exchange websites. The filing is made pursuant to SEBI LODR Regulations 30 and 47. The actual financial numbers are not included in this newspaper publication notice.

Likely market impact

This is a routine mandatory disclosure confirming Q4 and full-year FY2026 results have been duly approved and published. Shareholders should refer to the detailed results on the company website for actual financial performance. The stock may see movement once detailed numbers are analyzed.